MABSILICO
MAbSilico is a deeptech company from French academic research labs. Founded in 2017, MAbSilico is a software editor with the vision to accelerate the development of therapeutic antibody focusing on the early stage development to provide leads in a few years today to a few weeks. MAbSilico is developing a software suite combining algorithms and databases based on 20 years of proven research and protected by patent. Our Artificial Intelligence and machine learning -driven tools cover two key ste... ps of the early-stage antibody development; the lead identification and the lead characterization. Our aim is to help customers to select more effectively the best candidate, secure more efficiently their IP, by only using the DNA sequences of the antibodies. For epitope determination or off-targets prediction get ready to use the deeptech driven solutions of MAbSilico to select your best leads.
MABSILICO
Social Links:
Industry:
Artificial Intelligence Biotechnology Health Care Life Science Machine Learning Software
Founded:
2017-09-25
Address:
Nouzilly, Centre, France
Country:
France
Website Url:
http://www.mabsilico.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Universal Analytics Domain Not Resolving Euro Amazon Amazon Virginia Region Microsoft
Similar Organizations
AI Prescience
Improving Business Performance Using Artificial Intelligence, Machine Learning & Data
Bee the Data
Bee the Data offers software solutions in the scope of artificial intelligence and machine learning.
BIGDA Solutions
Big data solutions, business intelligence, artificial intelligence, machine learning
CellVision
CellVision is a computational system that discovers drug action in cells using image analysis and machine learning algorithms.
Granta Innovation
Research, consulting and development of AI and ML applications in business and healthcare
Hyppo
Hyppo uses groundbreaking artificial intelligence to revolutionize the way diseases are detected and diagnosed.
Kantify
We develop AI solutions for human life with a focus on healthcare, biotech and mobility.
Layke Analytics
Layke is an API solution for intelligent screening and matching candidates.
Remedium AI
Remedium is capitalizing on recent breakthrough developments in Artificial Intelligence.
RiskDataScience
RiskDataScience identifies and develops solutions for the financial services.
Skkiper
Skkiper builds a platform for buying and selling business using artificial intelligence and machine learning.
VerityXR
Healthcare Technology, Virtual Reality, Artificial Intelligence
Xdroid
Xdroid offers best-of-breed innovative artificial intelligence solutions in the field of machine learning.
Current Employees Featured
Founder
Official Site Inspections
http://www.mabsilico.com Semrush global rank: 6.14 M Semrush visits lastest month: 1.31 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "MAbSilico"
MAbSilico - Home
Better, faster & safer therapeutic antibody discovery. We are changing the process with AI-based solutions. How do we define the best lead candidate? AI-based docking and affinity prediction …See details»
About us - MAbSilico
MAbSilico has the technology to perform computational antibody drug design in 21 days, while integrating multi-parameter specifications to provide the best antibodies for your target. The company continues to develop new solutions to …See details»
MAbSilico - Crunchbase Company Profile & Funding
MAbSilico is a TechBio company developing and providing AI-based solutions for antibody drug design and discovery. We help biotech and pharma companies to leverage antibody discovery …See details»
MAbSilico - LinkedIn
We help biotech and pharma companies to leverage antibody discovery risks by providing computational candidates in days which are designed and characterized in silico and validated with...See details»
MAbSilico - Process
MAbSilico enables our partners to accelerate and improve the success rate in identifying the best lead candidates. Our epitope-driven antibody design uses a multi-parameter approach to design antibodies while taking into account …See details»
MabSilico - French Healthcare
Jan 9, 2021 · Thanks to a combination of computer-based and biological approaches, MAbSilico provides AI-driven solutions for the discovery of antibodies in just days, compared with …See details»
MAbSilico Company Profile - Office Locations, Competitors ... - Craft
MAbSilico is a company committed to the discovery and development of biomarkers and therapeutic antibodies for the biotech industry. It offers tools based on artificial intelligence and …See details»
MAbSilico | Scientist.com
We help biotech and pharma companies to leverage antibody discovery risks by providing computational candidates in days which are designed and characterized in silico and validated …See details»
MAbSilico - Products, Competitors, Financials, Employees, …
MAbSilico is a TechBio company that provides AI-based solutions for therapeutic antibody discovery and design in the biotech and pharmaceutical sectors. Use the CB Insights Platform …See details»
MAbSilico - Crunchbase
MAbSilico focuses on AI-driven antibody design, while Pera Labs specializes in digiceuticals and fertility solutions. Proscia and Emedgene offer computational pathology and genomic …See details»
MAbSilico - Company info. interviews, news - BiopharmaTrend
MAbSilico is a deeptech company from French academic research labs. Founded in 2017, MAbSilico is a software editor with the vision to accelerate the development of therapeutic …See details»
MAbSilico Locations - Contract Research Map
We help biotech and pharma companies to leverage antibody discovery risks by providing computational candidates in days which are designed and characterized in silico and validated …See details»
OSE Immunotherapeutics Announces Artificial Intelligence …
MAbSilico’s objective is to propose a software suite that creates a formal approach of antibody development, reducing the risks of failure and the duration of pre-clinical steps, as well as …See details»
Vincent Puard - CEO @ MAbSilico - Crunchbase Person Profile
Dr. Vincent Puard, co-founder and CEO of MAbSilico, holds a PhD in biology from the CHRU Bretonneau and INRA Tours and a master's degree in biomedicines from the University of …See details»
MAbSilico - Partner with us
MAbSilico enables its partners to identify the best lead candidates faster and better. Our epitope-driven antibody design uses multi-parametric approaches to design antibodies, while taking …See details»
MAbSilico | CipherBio
Explore MAbSilico's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
OSE Immunotherapeutics Expands its Collaboration with …
Jan 28, 2021 · OSE is advancing an "Immunotherapy 2.0" future by leveraging MAbSilico’s artificial intelligence-powered software solutions and professional services to accelerate and …See details»
MAbSilico - YouTube
MAbSilico provides a formal embedded Artificial Intelligence technology for antibody discovery, reducing the risks of failure and the duration of discovery and preclinical steps, as well as...See details»
MAbSilico is incorporated!
MAbSilico is incorporated! After years of collaborations in academia, we are thrilled to start the entrepreneur adventure! We cannot wait to continue to do beautiful science and to share our …See details»
☑️Mabsilico — Consulting Organization from France, experience …
Mabsilico — Consulting Organization from France, has experience with Horizon Europe (2021 - 2027), it`s involved in Information & Communication Technology sectorSee details»